{{knowledge objective
|Identifiant=OIC-036-16-A
|Item_parent=Contraception. (see item 330)
|Item_parent_short=Contraception. (see item 330)
|Rank=A
|Title=Awareness of potential drug interactions
|Description=None
|Topic=Monitoring and/or prognosis
|Contributors=GeneviÃ¨ve Plu-Bureau
|Order=16}}


=== '''Decreased contraceptive efficacy''' ===

==== Strong inducers such as
- Antiepileptics (phenobarbital, primidone, phenytoines, carbamazepine, felbamate, topiramate (dose > 200 mg/day), rufinadine, oxcarbazepine, primidone)

- Antiretrovirals (efavirenz, etravirine, lopinavir, nelfinavir, neviparin, ritonavir)

- Certain antibiotics (Rifampicin)

- Antidepressant (St John's wort)

- Vasodilator (bosentan)

==== Weak inducers such as ====
- Antifungal (griseofulvin)

- Psychostimulant (modafinil)

- Sedative (meprobamate)

- Antiemetic (aprepitant)

=== '''Decreased pharmacological effect''' ===
(risk of renewed epileptic seizures)

- Lamotrigine.